We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Laser Scattering Technique Detects Single Molecules

By LabMedica International staff writers
Posted on 21 Sep 2014
A recent paper described a novel technique for the label-free detection of single biomolecules such as tumor markers, proteins, or RNA fragments.

Investigators at the Max Planck Institute for the Science of Light (Erlangen, Germany) adapted a method called interferometric detection of scattering (iSCAT) to achieve the goal of label-free single molecule detection. More...


In this approach, which was described fully in the July 29, 2014, online edition of the journal Nature Communications, the investigators directed laser light onto a microscope slide on which proteins of interest had been captured with appropriate biochemical lures. The bound proteins scattered the laser light, thus casting a shadow. By comparing shadow diagrams before and after binding of the proteins of interest, the investigators could identify target proteins, which stood out clearly from the background as dark spots, even though the shadow of the protein was only one ten-thousandth or even one hundred-thousandth as dark as the background.

“In our method the scattering image of a protein is amplified and stripped of background noise. iSCAT not only promises more sensitive diagnosis of diseases such as cancers, but will also shed light on many fundamental biochemical processes in nature,” said senior author Dr. Vahid Sandoghdar, director of the nano-optics division of the Max Planck Institute for the Science of Light. “Until now it was thought that if you want to detect scattered light from nanoparticles, you have to eliminate all background light. However, in recent years we have realized that it is more advantageous to illuminate the sample strongly and visualize the feeble signal of a tiny nanoparticle as a shadow against the intense background light. The strength of our method lies not only in the fact that it is so sensitive and that we can count target proteins in a sample, iSCAT also shows us the exact position of particles.”

Related Links:

Max Planck Institute for the Science of Light



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The addition of Biocare’s complementary IHC antibody, reagent and instrument portfolio enhances Agilent’s immunohistochemistry offering (Photo courtesy of Biocare Medical)

Agilent Technologies Acquires Pathology Diagnostics Company Biocare Medical

Agilent Technologies (Santa Clara, CA, USA) has entered into a definitive agreement to acquire Biocare Medical (Pacheco, CA, USA), expanding its pathology portfolio through the addition of highly complementary... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.